Source: International Congress 2018 – New developments in the treatment of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Castro (St Louis, United States of America), Y. Adir (Haifa, Israel), P. Chanez (Marseille, France), M. Mcdonald (Malvern, United States of America), L. Hickey (Malvern, United States of America), M. Garin (Malvern, United States of America). Consistent efficacy across endpoints with reslizumab despite short term variability in blood eosinophil levels. 1043

Member's Comments

No comment yet.

Related content which might interest you: Blood eosinophils in COPD: long term variability and clinical outcomes Source: International Congress 2017 – Innovation in COPD: techniques and facts Year: 2017 Short term reductions in inhaled glucocorticoid doses in children with asthma may be associated with increased levels of serum eosinophil protein X Source: Eur Respir J 2001; 18: Suppl. 33, 451s Year: 2001 Consistently low blood lymphocytes in smokers are associated with worse clinical outcomes. Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Impact of blood eosinophil variability in asthma: a real-life population study. Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021 A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial Source: Eur Respir J, 58 (3) 2004522; 10.1183/13993003.04522-2020 Year: 2021 Variability and lack of predictive ability of asthma end-points in clinical trials Source: Eur Respir J 2002; 20: 1102-1109 Year: 2002 The association of the oxygen saturation level at the time of hospitalization with comorbidities and subsequent changes in blood biomarkers in patients with COVID-19 in Russia: observational study results. Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021 Impact of long-term oxygen therapy on morphological changes of red blood cells and NT-proBNP level in COPD patients. Source: International Congress 2017 – COPD biomarkers Year: 2017 Lack of seasonal variability of blood eosinophil counts in COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 A preliminary study to identify correlations between blood glucose levels and cardiorespiratory observations in acute asthma patients receiving nebulised salbutamol. Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Evaluation of the association between eosinophil variability and effects of inhaled corticosteroids in COPD patients using propensity score matching Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD Source: Eur Respir J, 55 (5) 1902119; 10.1183/13993003.02119-2019 Year: 2020 Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Low versus high Th2 asthma: variability of blood eosinophil counts in a longitudinal analysis Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Intravenous (IV) reslizumab efficacy does not differ by blood eosinophil lowering to levels above or below 50 cells/µL Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 The effect of statin usage on airway inflammatiory cells and markers, and clinical indices in asthmatic patients Source: Annual Congress 2011 - Asthma management and response Year: 2011 The effectiveness of different clinical measures in evaluating response to omalizumab Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma Year: 2010 A preliminary study to determine the effects of nebulised salbutamol on blood glucose levels during an acute asthma exacerbation. Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in patients with OSAS with emphasis on gender differences Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011